No Data
No Data
No Data
No Data
No Data
Express News | Needham Reiterates Buy on Merus, Maintains $66 Price Target
Moomoo 24/7Apr 11 05:42 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: ZimVie Inc (ZIMV) and Merus (MRUS)
TipRanksApr 11 05:40 ET
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models With High NRG1 Expression at the AACR Annual Meeting 2024
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS) ("Merus", "the Company", "we", or "our"), a clinical-stage oncology company developing innovative, full-length
GlobeNewswireApr 8 12:00 ET
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibo
GlobeNewswireApr 3 08:00 ET
Merus Initiated at Buy by Truist Securities
Merus Initiated at Buy by Truist Securities
Dow JonesMar 28 11:43 ET
Express News | Truist Securities Initiates Coverage On Merus With Buy Rating, Announces Price Target of $69
Moomoo 24/7Mar 28 11:34 ET
No Data
No Data